Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts by Zeidan, AM, Boddu, PC, Patnaik, MM, Bewersdorf, JP, Stahl, M, Rampal, RK, Shallis, R, Steensma, DP, Savona, MR, Sekeres, MA, Roboz, GJ, DeAngelo, DJ, Schuh, AC, Padron, E, Zeidner, JF, Walter, RB, Onida, F, Fathi, A, DeZern, A, Hobbs, G, Stein, EM, Vyas, P, Wei, AH, Bowen, DT, Montesinos, P, Griffiths, EA, Verma, AK, Keyzner, A, Bar-Natan, M, Navada, SC, Kremyanskaya, M, Goldberg, AD, Al-Kali, A, Heaney, ML, Nazha, A, Salman, H, Luger, S, Pratz, KW, Konig, H, Komrokji, R, Deininger, M, Cirici, BX, Bhatt, VR, Silverman, LR, Erba, HP, Fenaux, P, Platzbecker, U, Santini, V, Wang, ES, Tallman, MS